ADM Diagnostics, Inc. has received FDA clearance for CorInsights MRI. Using a standard MRI scan, CorInsights MRI provides quantitative information about brain tissue volume for use by radiologists and neurologists, as well as clinical researchers. This information can help to provide important insight related to potential causes of symptoms such as cognitive impairment. This product is one of ADMdx’s multiple innovations to improve the diagnosis and development of effective therapeutics for Alzheimer’s disease and other dementias.